"10.1371_journal.pone.0087009","plos one","2014-01-24T00:00:00Z","Andrew B Newberg; Mijail Serruya; Andrew Gepty; Charles Intenzo; Todd Lewis; Daniel Amen; David S Russell; Nancy Wintering","Myrna Brind Center of Integrative Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America; Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America; Department of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America; Magee Rehabilitation Hospital, Philadelphia, Pennsylvania, United States of America; Amen Clinics, Inc., Newport Beach, California, United States of America; Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States of America; Yale University School of Medicine, New Haven, Connecticut, United States of America","Conceived and designed the experiments: ABN MS CI TL DA DR NW. Performed the experiments: ABN MS AG CI TL DA DR NW. Analyzed the data: ABN MS AG CI TL DA DR NW. Contributed reagents/materials/analysis tools: ABN MS AG CI TL DA DR NW. Wrote the paper: ABN MS AG CI TL DA DR NW.","Dr. Andrew Newbergs Institution received a grant from GE Healthcare in order to perform the study reported in the paper. However, GE Healthcare had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Daniel Amen is employed by the commercial company, Amen Clinics, Inc. Dr. John Russell is employed by the commercial company, Molecular Neuroimaging. These affiliations do not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.",NA,NA,NA,"2014","01","Andrew B Newberg","ABN",8,TRUE,7,8,8,8,TRUE,TRUE,FALSE,0,NA,FALSE
